QUINTA-ANALYTICA
Zdenek Panek is an accomplished business manager currently at QUINTA-ANALYTICA since October 2020, where responsibilities include client management, project initiation, price proposal negotiations, and key account management. Previous roles include Senior Portfolio Manager at Zentiva and Sanofi, emphasizing portfolio development, strategic forecasting, and M&A support. Zdenek has significant experience in managing complex pharmaceutical projects and partnerships, having served in various capacities at Zentiva, including Global Senior Portfolio Building Manager and Head of International Projects. Early career experiences include positions as Head of Production and Research Chemist in the PolyPeptide Group, coupled with a solid educational background in Organic Chemistry from Charles University.
QUINTA-ANALYTICA
Quinta is a GCP/GLP/GMP-certified, EMA and FDA-inspected European CRO offering in-house clinical testing, pharmaceutical analysis, CMC and R&D. Quinta specializes in clinical studies, bioanalytics, method development and quality control for both small and large molecules, human and veterinary IMPs as well as generics. We provide unrivaled expertise to worldwide pharmaceutical and biotechnological clients across the entire pharma spectrum. Quinta is part of the Conscio group with headquarters in Munich, Germany, laboratories in Czechia, Austria, Slovakia, Germany and offices in the USA. Our main service areas include: 1) Clinical Testing: With 2 in-house clinical units providing BE/BA/PK studies, with capacity for 60+40 beds. 2) Bioanalytical Testing: GLP/GCP solutions for preclinical & clinical studies, small & large molecules, BE/BA/PK. 3) Research & Development: Analytical R&D, impurities, extractables & leachables, degradation, trace studies. 4) Pharmaceutical Quality Control: GMP quality control, batch testing, stabilities, HAPIs, inhalation, API sourcing. 5) Microbiology: GMP sterile & non-sterile testing, microbial/water analyses, endotoxins, antibiotics & vitamins. 6) Biopharmaceutical Quality Control: GLP/GMP bioanalysis, CMC, characterizations of peptide & protein IMPs, biosimilars. Quinta was founded in 1997 and has been successfully inspected by FDA more than 10 times. Quinta is headquartered in Prague, Czech Republic.